Search Within

Sheng Feng Cai

Formats
  1. Journal Article (26)
  2. Meeting Abstract (20)
  3. Review (3)
  4. Editorial (2)
  5. Research Letter (1)
Groups
  1. Adult Leukemia (52)
  2. Center for Hematologic Malignancies (52)
  3. Department of Medicine (52)
  4. Hematologic Malignancies, Division of (52)
  5. Hematology-Oncology Fellows (52)
  6. GSK Faculty (36)

More Groups

People
  1. Ross Levine (34)
  2. Eytan Stein (22)
  3. Christopher Famulare (19)
  4. Martin Tallman (19)
  5. Aaron Goldberg (17)
  6. Wenbin Xiao (17)

More People

Years
  1. 2025 (6)
  2. 2024 (8)
  3. 2023 (10)
  4. 2022 (4)
  5. 2021 (4)
  6. 2020 (5)

More Years

Publications
  1. Blood (20)
  2. Blood Advances (5)
  3. Cancer Discovery (4)
  4. American Journal of Hematology (2)
  5. Cancer Cell (2)
  6. Nature (2)

More Publications

Publishers
  1. American Society of Hematology (25)
  2. American Association for Cancer Research (6)
  3. Cell Press (5)
  4. Elsevier Inc. (2)
  5. John Wiley & Sons, Inc. (2)
  6. Nature Publishing Group (2)

More Publishers

Results (52)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A view of myeloid transformation through the hallmarks of cancer
    Review

    Fernández-Maestre, I.; Cai, S. F.; Levine, R. L.
    Blood Cancer Discovery (2024)

    Fulltext@MSK | Save
  • CRISPR dependency screens in primary hematopoietic stem cells identify KDM3B as a genotype-specific vulnerability in IDH2- and TET2-mutant cells
    Journal Article

    Waarts, M. R.; Mowla, S.; Boileau, M.; Martinez Benitez, A. R.; Sango, J.; Bagish, M.; Fernández-Maestre, I.; Shan, Y.; Eisman, S. E.; Park, Y. C.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Jak2(V617F) reversible activation shows its essential requirement in myeloproliferative neoplasms
    Journal Article

    Dunbar, A. J.; Bowman, R. L.; Park, Y. C.; O'Connor, K.; Izzo, F.; Myers, R. M.; Karzai, A.; Zaroogian, Z.; Kim, W. J.; Fernandez-Maestre, I.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2-mutant AML
    Journal Article

    Cai, S. F.; Huang, Y.; Lance, J. R.; Mao, H. C.; Dunbar, A. J.; McNulty, S. N.; Druley, T.; Li, Y.; Baer, M. R.; Stock, W.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • PRC2-mediated apoptosis evasion is a therapeutic target of MDS/AML harboring inv(3)/t(3;3) and-7
    Meeting Abstract

    Kunimoto, H.; Miura, A.; Sagisaka, M.; Ito, M.; Honma, D.; Tsutsumi, S.; Sakuma, T.; Ohashi, T.; Teranaka, H.; Ikeda, J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia
    Meeting Abstract

    Sirenko, M.; Lee, S.; Sun, Z.; Chaligne, R.; Asimomitis, G.; Brierley, C. K.; Bernard, E.; Cai, S. F.; Myers, R. M.; Nadorp, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • 15 years after a giant leap for cancer genomics
    Editorial

    Cai, S. F.; Levine, R. L.
    Nature (2023)

    Fulltext@MSK | Save
  • Targeting JAK1 signaling for molecular prevention in clonal hematopoiesis
    Meeting Abstract

    Vela, P. S.; Wang, R.; Tran, D.; Benitez, A. M.; Krishnan, A.; O'Connor, K.; Liu, W.; Kleppe, M.; Bowman, R.; Cai, S.; more...
    Experimental Hematology (2023)

    Fulltext@MSK | Save
  • Targeting JAK1 signaling for molecular prevention in clonal hematopoiesis
    Meeting Abstract

    Sánchez Vela, P.; Benitez, A. M.; Krishnan, A.; Kleppe, M.; Cai, S. F.; Levine, R. L.
    Cancer Prevention Research (2023)

    Fulltext@MSK | Save
  • Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia
    Journal Article

    McCarter, J. G. W.; Nemirovsky, D.; Famulare, C. A.; Farnoud, N.; Mohanty, A. S.; Stone-Molloy, Z. S.; Chervin, J.; Ball, B. J.; Epstein-Peterson, Z. D.; Arcila, M. E.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save